Acromegaly: a unique human headache model.
Levy
Miles J
MJ
Headache Group, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.
Bejon
P
P
Barakat
M
M
Goadsby
Peter J
PJ
Meeran
K
K
D000172:Acromegaly / Q000209:etiology / Q000378:metabolism*; D000328:Adult; D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006261:Headache / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D008954:Models, Biological; D015282:Octreotide / Q000494:pharmacology* / Q000627:therapeutic use; D010456:Peptides, Cyclic / Q000494:pharmacology / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications / Q000378:metabolism; D017481:Receptors, Somatostatin / Q000187:drug effects*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D000700:Analgesics; D010456:Peptides, Cyclic; D017481:Receptors, Somatostatin; C060347:lanreotide; D019382:Human Growth Hormone; D013004:Somatostatin; D015282:Octreotide